Live Updates Live Coverage Updates appear automatically as they are published. What Wall Street Will Be Watching In Charles Schwab's Earnings Call 7:03 am by Eric Bleeker Here are some of the key storylines headed into Q2 earnings for Schwab.

UnitedHealth stock is deeply oversold, undervalued, and primed for a recovery. Read why analysts forecast UNH to have a ~29% upside and improved confidence ahead.

Johnson & Johnson (NYSE: JNJ) ranks among the best forever stocks to invest in. Prior to the company’s second-quarter earnings report on July 16, Goldman Sachs reaffirmed its Conviction Buy rating on Johnson & Johnson (NYSE:JNJ) on July 10 with a price target of $177.

Live Updates Live Coverage Updates appear automatically as they are published. CEO Commentary 7:53 am “SLB reported solid second-quarter results, leveraging our diversified portfolio and broad market exposure to deliver steady revenue and slightly higher adjusted EBITDA and margins sequentially.

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my JNJ earnings update.

Netflix is due to report second-quarter results after the close of trading Thursday, with Wall Street eagerly anticipating a strong kickoff to media earnings season from the giant streamer. "Currently,

Netflix exceeded Wall Street earnings expectations for the second quarter, driven by the final season of global phenomenon “Squid Game,” but shares dropped 1.8% to $1,897 in after-hours trading as investors expressed disappointment with the company’s conservative revenue guidance for 2025.

Recent portfolio additions are yielding slightly below the 7.6% core yield reported for Q2 2025, as noted by Jason Estes. Expense Outlook: Projected Q3 total expenses of $10 million, split between $1 million in oil and gas and $9 million in other expenses,